Zobrazeno 1 - 10
of 527
pro vyhledávání: '"Lluís, Puig"'
Autor:
Lluís Puig, Hideki Fujita, Diamant Thaçi, Min Zheng, Ana Cristina Hernandez Daly, Craig Leonardi, Mark G. Lebwohl, Jonathan Barker
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 9, Pp 2331-2378 (2024)
Abstract Generalized pustular psoriasis (GPP) is a rare, chronic and potentially life-threatening autoinflammatory skin disease characterized by widespread eruption of sterile pustules, with or without systemic inflammation. GPP can significantly red
Externí odkaz:
https://doaj.org/article/6a3c54cabc414da3a8ccb8b021e75083
Autor:
Simon Francis Thomsen, Valeria Corazza, Matthias Augustin, Elizabeth Lazaridou, Lluís Puig, Loïc Guillevin
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 7, Pp 1705-1708 (2024)
Externí odkaz:
https://doaj.org/article/03308b5e65ef4bf0a6e461f5c0812a22
Autor:
Francisco J. Ortiz de Frutos, Ana M. Giménez‐Arnau, Lluís Puig, Juan F. Silvestre, Esther Serra, Laura Salgado‐Boquete, Vicente García‐Patos, Jose L. L. Estebaranz, Jaime Notario, Ana Martin‐Santiago, Gabriel M. Pontevia, Víctor Martín, Guillermo Guinea, Pau Terradas, Esteban Daudén
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 4, Pp 775-785 (2023)
Abstract Background Accurately determining the epidemiology of dermatological diseases such as hidradenitis suppurativa (HS), psoriasis (PsO), chronic urticaria (CU) and/or atopic dermatitis (AD) is challenging due to variations in prevalence and dis
Externí odkaz:
https://doaj.org/article/5fd09b7f16c4403ba7b16514dc4709a6
Autor:
Pablo de laCueva, Susana Armesto, Encarnacion Montesinos, Francisco Javier García, Ana Maria Morales, Raquel Rivera‐Díaz, Mercedes Hospital, Jordi Mollet, Mar Llamas‐Velasco, Jose‐Manuel Carrascosa, Mercedes García, Jimena Vázquez, Lluís Puig
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 3, Pp 488-501 (2023)
Abstract Background Despite the proven efficacy and safety of apremilast to treat plaque psoriasis (PsO), data regarding its real‐world use and patient‐perceived benefits are limited. Objectives Describe apremilast use, persistence and tolerabili
Externí odkaz:
https://doaj.org/article/ae828610197749e49fb5192e7531b1f0
Autor:
Lluís Rusiñol, Lluís Puig
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8437 (2024)
Atopic dermatitis and psoriasis are prevalent inflammatory skin conditions that significantly impact the quality of life of patients, with diverse treatment options available. Despite advances in understanding their underlying mechanisms, recent rese
Externí odkaz:
https://doaj.org/article/f8dc4e346e134b2695ab6a898bcc7bab
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Purpose: There is a paucity of evidence on the impact of immune-mediated inflammatory disease (IMID) treatments on the immunogenicity of SARS-CoV-2 vaccination. The purpose of this literature review is to address the question of whether patients with
Externí odkaz:
https://doaj.org/article/a969977544a64076b64e7d271ff94fcd
Autor:
Jan Koren, Jo L. W. Lambert, Simon F. Thomsen, Helen McAteer, Gabriella Fabbrocini, Valeria Corazza, Denis Jullien, Matthias Augustin, Richard B. Warren, Menno A. de Rie, Elizabeth Lazaridou, Lluís Puig, Loïc Guillevin, Marius Grosser, Wolf-Henning Boehncke
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 1, Pp 245-268 (2022)
Abstract Introduction Despite advances in treatment options and the management of patients with psoriasis, considerable unmet needs remain. Our objective was to identify ways to elevate the standard of care for patients with psoriasis by combining th
Externí odkaz:
https://doaj.org/article/145054bef9b34a5bb9af8c12698ca3ad
Autor:
Lluís Puig, Kave Shams, Fabricio Furlan, Cristofer Salvati, Elisa Romero, Jamie Fan, Lars Iversen
Publikováno v:
Biologics, Vol 2, Iss 4, Pp 213-225 (2022)
SDZ-ADL is a biosimilar of reference adalimumab. Here, the safety and effectiveness data of SDZ-ADL from the British Association of Dermatologists Biologic and Immuno-modulators Register (BADBIR) are reported. In the safety set, data of SDZ-ADL were
Externí odkaz:
https://doaj.org/article/ab9e65cf45f24a4996cb8c8c9cc24242
Publikováno v:
Pharmaceutics, Vol 16, Iss 2, p 239 (2024)
The introduction of biologic therapies has led to dramatic improvements in the management of moderate-to-severe psoriasis. Even though the efficacy and safety of the newer biologic agents are difficult to match, oral administration is considered an i
Externí odkaz:
https://doaj.org/article/44e4c44a767346fe95a014887f67db90
Autor:
Lluís Rusiñol, Lluís Puig
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 2, p 1042 (2024)
Psoriasis and atopic dermatitis fall within the category of cutaneous immune-mediated inflammatory diseases (IMIDs). The prevalence of IMIDs is increasing in industrialized societies, influenced by both environmental changes and a genetic predisposit
Externí odkaz:
https://doaj.org/article/7a4ec48b739e447b8dc9ab08cf09711e